Vimarsana
Biggest News Aggregation in the World

Matthew Lunning News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Matthew Lunning. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Matthew Lunning Today - Breaking & Trending Today

Revisit Every OncLive On Air Episode from March 2024 - Vimarsana News

Revisit Every OncLive On Air Episode from March 2024

In case you missed any, below is a recap of every episode of OncLive On Air that aired in March 2024.

Lunning and Rutherford Detail Considerations for BV-AVD Use in Older Patients With Hodgkin Lymphoma - Vimarsana News

Lunning and Rutherford Detail Considerations for BV-AVD Use in Older Patients With Hodgkin Lymphoma

Drs Lunning and Rutherford discuss findings from the ECHELON-1 trial of BV-AVD in the cohort of patients with Hodgkin lymphoma over 60 years of age.

Lunning and Maddocks Talk Through Frontline MCL Management - Vimarsana News

Lunning and Maddocks Talk Through Frontline MCL Management

Drs Lunning and Maddocks discuss the management of MCL in the up-front setting.

Bispecific T-cell Engagers as Third-line and Beyond Therapy for FL - Vimarsana News

Bispecific T-cell Engagers as Third-line and Beyond Therapy for FL

Matthew Lunning, DO, discusses recent data on bispecific T-cell engagers as third-line and beyond therapy for FL.

Lunning and Mehta-Shah Unpack Treatment Needs and Future Directions in PTCL - Vimarsana News

Lunning and Mehta-Shah Unpack Treatment Needs and Future Directions in PTCL

Drs Lunning and Mehta-Shah highlight challenges that arise when diagnosing patients with peripheral T-cell lymphoma and how molecular testing results influence induction and consolidation treatment approaches for patients with ALK-negative anaplastic large cell lymphoma.